Clinical Trials Browser

Completed × Kidney Neoplasms × Bevacizumab × Clear all

NCT01130519 2025-02-21

A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer

Phase 2 Completed

83 enrolled 17 charts

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, Kidney Neoplasms

NCT02724878 2025-02-13

Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

Phase 2 Completed

65 enrolled 30 charts

Kidney Neoplasms

NCT00113217 2020-09-23

Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma

Phase 2 Completed

52 enrolled 5 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00853021 2019-06-05

Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney

Phase 2 Completed

26 enrolled 11 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00782275 2018-01-24

Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

Phase 2 Completed

41 enrolled 9 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00496587 2017-07-19

Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma

Phase 2 Completed

34 enrolled 9 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01283048 2016-09-21

Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma

Phase 1 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00072046 2016-07-06

Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)

Phase 3 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00631371 2016-04-27

INTORACT

Phase 3 Completed

791 enrolled 11 charts

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms

NCT00455975 2014-12-22

High-dose Bevacizumab in Advanced Renal Carcinoma Patients

Phase 2 Completed

119 enrolled 8 charts

Kidney Neoplasms, Adenocarcinoma, Clear Cell

NCT00193154 2014-04-01

OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma

Phase 2 Completed

Kidney Neoplasms

NCT00323739 2013-07-26

Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma

Phase 2 Completed

80 enrolled 8 charts

Kidney Neoplasms

NCT00421512 2008-11-11

A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients

Phase 1 Completed

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis